ABSTRACT
Risk of urinary incontinence (UI) increases with age and can have detrimental effects on patients and caregivers. UI should not be considered a normal part of aging and warrants a comprehensive evaluation. Treatment of UI in the aging male requires special consideration, particularly when it comes to comorbid conditions and potential side effects of intervention. The aim of this review is to discuss the evaluation of, risk factors for, and management of UI in the aging male.
Acknowledgments
None stated.
Declaration of financial/other relationships
Amy Pearlman is a consultant for and receives grant funding from Boston Scientific.
Karl Kreder receives grant funding from Boston Scientific.
Disclosure statement
Amy Pearlman is a consultant for and receives grant funding from Boston Scientific.
Karl Kreder receives grant funding from Boston Scientific.
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.